ArticleResearch square2026
Life-Course Fertility and Cardio-Kidney-Metabolic Health in Chinese Middle-Aged and Older Women: A Cross-Sectional CHARLS Study.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Background: The cardio-kidney-metabolic (CKM) syndrome, recently conceptualized by the American Heart Association (AHA) in 2023, integrates cardiovascular, renal, and metabolic dysfunction into a unified staging framework. To date, no study worldwide has examined the association between parity and CKM syndrome stages. Fertility history may influence long-term metabolic health through hormonal fluctuations, inflammatory responses, and cumulative physiological stress. This cross-sectional design cannot support causal inference. Methods: We analyzed 4,814 women aged 45 years and older with complete blood biomarker data from the China Health and Retirement Longitudinal Study (CHARLS, 2011-2018). CKM stages were classified using objective biomarkers including cystatin C-based estimated glomerular filtration rate (eGFR). Parity was categorized as 0, 1, 2 (reference), 3, 4-5, and 6 or more. Poisson regression with robust standard errors estimated adjusted prevalence ratios (aPR). Restricted cubic splines (RCS) assessed dose-response relationships. Exploratory factor analysis identified multimorbidity patterns. Multiple imputation by chained equations (MICE) addressed missing data. Results: The prevalence of CKM Stage 2 or higher was 53.2%. Parity demonstrated a U-shaped association with CKM syndrome. Compared with parity = 2, aPRs were: parity = 1: 0.88 (95% CI: 0.75-1.02, P = 0.078); parity 6 or more: 0.87 (95% CI: 0.74-1.03, P = 0.110). RCS analysis confirmed a nonlinear dose-response with the nadir at parity = 2-3 (Wald P = 0.042). Factor analysis revealed three multimorbidity patterns: respiratory-cardio-arthritic (beta = + 0.026, P = 0.001), cardio-metabolic (beta approximately 0, P = 0.98), and digestive-arthritic-renal (beta = + 0.014, P = 0.020). MICE analysis (n = 7,236) confirmed directionally consistent findings. Conclusions: Parity exhibits a U-shaped association with CKM syndrome in Chinese middle-aged and older women, suggesting a "healthy mother effect" with dual protective pathways. These findings support integrating fertility history into sex-specific CKM risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.